Maturation of blast cells in acute transformation of chronic myeloproliferative syndrome.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to F Carbonell.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The distribution of Glm(f, z, a and x), G3m(b0, b1, b3, b5, c3, c5, g, s and t), A2m (1 and 2) and Km(1) allotypic determinants in a series of Spanish blood donors. The following results were obtained: Gmz,a;gAm1 = 0.199; Gmz,a;gAm2 = 0.019; Gmz,a,x;gAm1 = 0.081; Gmz,a,x;gAm2 = 0.005; Gmf;bAm1 = 0.677; Gmz,a;bAm1 = 0.019 and Km1 = 0.096. The results are similar to those reported for adjacent Basque and Portuguese populations. The origin of the Gmz,a;bAm1 haplotype is unknown.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A case of autoimmune hemolytic anemia associated with chronic ulcerative colitis in a 28-year-old woman is reported. Immunological studies showed a strongly positive direct Coombs test of IgG type and a non-specific pannagglutinin antibody. This immunological pattern remained for 10 months instead of the medical treatment with corticosteroids and azathioprine. A subtotal colectomy with ileo-rectostomy was performed and the patient experienced a greater clinical improvement, though the total negativity of the immunitary alteration was not obtained. Weak immunological disturbances continued 19 months after the surgical procedure. A short review of the literature is presented and a total of 39 cases of erythorcitic autoimmunization (with or without hemolysis) published up to the present time have been found. Lastly, various etiopathogenic theories in relation to this complication are mentioned.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.